SCHEMBL7857544

SCHEMBL7857544

Cc1noc(NS(=O)(=O)c2ncccc2C(=O)Nc2ccccc2)c1C

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.66
RXFP1 Q9HBX9 3/20 0.61
MAPT P10636 4/20 0.61
EDNRA P25101 3/20 0.60
POLB P06746 3/20 0.56
TDP1 Q9NUW8 2/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
HSD17B10 Q99714 1/20 0.56
HPGD P15428 1/20 0.55
EDNRB P24530 1/20 0.54
TP53 P04637 1/20 0.53
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
ALDH1A1 P00352 2/20 0.52
CNR1 P21554 2/20 0.51
GPR55 Q9Y2T6 2/20 0.51
LMNA P02545 1/20 0.51
MAPK1 P28482 1/20 0.51
RECQL P46063 1/20 0.51
DUSP3 P51452 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7857592 0.89 EDNRA (0.62) KDM4ERXFP1MAPTEDNRAEDNRB
SCHEMBL7850006 0.80 MEN1 (0.46) KDM4ERXFP1MAPTEDNRATDP1
SCHEMBL7338921 0.80 EDNRA (0.71) KDM4ERXFP1MAPTEDNRAPOLB
SCHEMBL6959046 0.80 EDNRA (0.71) KDM4ERXFP1MAPTEDNRAPOLB
SCHEMBL11344287 0.75 PRKCI (0.67) KDM4EMAPTTDP1HSD17B10HPGD
SCHEMBL6151684 0.75 EDNRA (1.00) EDNRAEDNRB
SCHEMBL7716850 0.71 EDNRA (1.00) EDNRAEDNRBMEN1KMT2A
SCHEMBL17689189 0.71 TP53 (0.81) KDM4ERXFP1MAPTPOLBTDP1
SCHEMBL7856729 0.71 EDNRA (0.67) EDNRAEDNRB
SCHEMBL11752890 0.70 EDNRA (0.66) EDNRAEDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1069114-A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin TEXAS BIOTECHNOLOGY CORPORATION (US) 2001-01-17 EP claimed
EP-0870764-A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin TEXAS BIOTECHNOLOGY CORPORATION (US) 1998-10-14 EP claimed
US-5571821-A CARDIOVASCULAR DISORDERS TO MODULATE ENDOTHELIN, HYPOTENSIVE AGENTS AND VASOCONSTRICTION TEXAS BIOTECHNOLOGY CORPORATION (US) 1996-11-05 US claimed
EP-1069114-A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin TEXAS BIOTECHNOLOGY CORPORATION (US) 2001-01-17 EP disclosed
EP-0870764-A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin TEXAS BIOTECHNOLOGY CORPORATION (US) 1998-10-14 EP disclosed
US-5571821-A CARDIOVASCULAR DISORDERS TO MODULATE ENDOTHELIN, HYPOTENSIVE AGENTS AND VASOCONSTRICTION TEXAS BIOTECHNOLOGY CORPORATION (US) 1996-11-05 US disclosed
EP-0699191-A1 SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN TEXAS BIOTECHNOLOGY CORPORATION (US) 1996-03-06 EP disclosed
WO-1994027979-A1 SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN IMMUNOPHARMACEUTICS, INC. (US) 1994-12-08 WO disclosed